Translational Safety Biomarker Pipeline: Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Joined April 2019
- Tweets147
- Following52
- Followers96
- Likes103
IMI2_TransBioLine retweeted
🔛Final 9 TransBioLine F2F meeting in London. #H2020 #EUHealthResearch @IMITransBioLine
☑️Close to the project end, the focus is on the dissemination of results and sustainability.
☑️Promising results on DILI #biomarkers can be expected shortly. @StirnimannGuido
IMI2_TransBioLine retweeted
Novel DILI biomarker cytokeratin-18 is sensitive in chronic dosing study. @IMITransBioLine
pubmed.ncbi.nlm.nih.gov/3852…
IMI2_TransBioLine retweeted
C-Path's Nicholas King will be onsite at next week's @NIH and @NIDDKgov Kidney Precision Medicine Clinical Trials Workshop.
IMI2_TransBioLine retweeted
World Patient Safety Day 2023 recognizes the crucial role that patients, families and caregivers play in the safety of #healthcare.
Engaging patients for patient safety!
#WorldPatientSafetyDay #PatientSafety #WPSD23
IMI2_TransBioLine retweeted
Checking potential medicines won't damage our vital organs is a major challenge in #DrugDevelopment
@IMITransBioLine is is identifying new markers that flag up when a medicine may be harmful to organs like the liver or kidneys
Read more europa.eu/!p6D6Nb
#SummerReading
IMI2_TransBioLine retweeted
IMI project news:📢 @IMITransBioLine is identifying new markers that flag up when a medicine might be harmful to vital organs like the liver or kidneys.
Find out more: bit.ly/3wPBGHa
#H2020 #EUHealthResearch #MedicineSafety
IMI2_TransBioLine retweeted
Excited to share the results of our study that will hopefully influence clinical practice. @JHepatology @NottmBRCLiverGI. Thanks to all involved. Risk of liver fibrosis associated with long-term methotrexate therapy ... sciencedirect.com/science/ar…
IMI2_TransBioLine retweeted
It was a pleasure to organise the successful 5th @IMITransBioLine Consortium Meeting in Barcelona where all project team members met F2F for the first time after the pandemic
Read more⬇️
synapse-managers.com/synapse…
@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch
IMI2_TransBioLine retweeted
Nathalie Bofarull (@NBofarull), our Senior Project Manager, shared additional topics on sustainability at the @IMITransBioLine 5th Consortium Meeting, the latest F2F event we organised in Barcelona
@IHIEurope
#IHICarrytheTorch #H2020 #EUHealthResearch
IMI2_TransBioLine retweeted
Our Senior Project Manager, Estefanía Callado, had the opportunity to present an overview of Project Management and Communication at the @IMITransBioLine 5th Consortium Meeting celebrated recently in Barcelona
@IHIEurope #IHICarrytheTorch #H2020 #EUHealthResearch
IMI2_TransBioLine retweeted
📢 All set to start #15thConsortiumMeeting in #Barcelona
Consortium members are gathering to three simultaneous use case sessions to test the eTRANSAFE ToxHub
@IHIEurope
#H2020 #toxicology #insilico #drugsafety
IMI2_TransBioLine retweeted
Thank you @NICESciAdvice @NICEComms for the invitation to present the work we have been doing in our @EU_Commission funded @HTx_H2020 project. @CHEyork #HTA #HEOR #CausalInference
IMI2_TransBioLine retweeted
@IMI_JU’s @IMITransBioLine aims to discover and develop new safety biomarkers for early clinical trials—and recently made advancements in the potential implementation of new kidney, liver, vascular and CNS biomarkers. Read more from the FDA. #PFEColleague bit.ly/3G5McMr
IMI2_TransBioLine retweeted
Working in public-private partnerships is really important says @kremer_andreas of ITTM at #ImpactSeriesIMI event on #SMEs. ITTM is involved in multiple projects incl. @IMI_EHDEN @OPTIMA_oncology @t2evolve_imi @ImmUniverse_EU @Imsavar_IMI2 @Biomap_IMI @IMITransBioLine
IMI2_TransBioLine retweeted
Worthwhile and interesting meeting where Carlos Díaz has talked about systems leadership and the relevant role that @NICEComms is playing in different European projects managed by Synapse.
.@IMI2_NEURONET project coordinator Carlos Díaz @SynapseManagers is highlighting the excellent collaboration with @NICEComms in @IHIEurope research projects & underlines great outputs such as our HTA/regulatory decision tool ⤵️
kb.imi-neuronet.org/
IMI2_TransBioLine retweeted
@IMI_JU’s @IMITransBioLine aims to discover and develop new safety biomarkers for early clinical trials—and recently made advancements in the potential implementation of new kidney, liver, vascular and CNS biomarkers. Read more from the FDA. #PFEColleague bit.ly/3n1pTky
IMI2_TransBioLine retweeted
A multiscale QST model for drug-induced liver injury and biomarkers showcased tomorrow by Vipul Gupta @Certara
@etransafe and @IMITransBioLine colleagues invited!
#insilico #drugsafety #drugdiscovery
IMI2_TransBioLine retweeted
The last part of our Model Implementation Webinar Series starts today! Presentation of the TXG-MAPr tool for the assessment of drug-induced liver and kidney toxicity by S. Kunnen @UniLeiden. TransQST, eTRANSAFE & TransBioLine members are invited to join #drugsafety #drugdiscovery
IMI2_TransBioLine retweeted
How can Quantitative Systems Toxicology models help to assess intestinal epithelial toxicity provoked by cancer treatment? We invite TransQST, eTRANSAFE and TransBioLine members to join our Model Implementation Webinar tomorrow by C. Pin @AstraZeneca
#drugsafety #drugdiscovery
